Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Nutritional supplementation for older adults with hip fractures

Official title: Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures

Run by NYU Langone Health · NCT06773000 · Data updated 2026-11-12

This study tests whether a special nutritional supplement can help older adults with hip fractures keep their muscle strength during recovery compared to regular nutritional advice.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment118 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 16, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedMarch 3, 2026
Trial IDNCT06773000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 65 years or older who have sustained a geriatric hip fracture requiring surgical intervention.

Probably not a fit

Patients with pre-existing mobility impairments or severe organ dysfunction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the outcomes of older adults with hip fractures who receive a specific nutritional supplement to those who receive standard nutritional counseling. Participants will be randomly assigned to either the supplement group or the control group and monitored for muscle loss through ultrasound measurements of the rectus femoris muscle in the uninjured leg. The study aims to determine if the nutritional supplement can effectively reduce muscle loss during the recovery period following surgery.

Why it matters

Potential benefit: If successful, this study could help improve recovery outcomes and reduce muscle loss in older adults after hip fractures.

How similar studies have gone: Other studies have shown promising results with nutritional supplementation in similar populations, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female, aged 65 years or older.
2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention.
3. Able to provide informed consent.
4. Expected to survive at least 6 months after surgery, with no terminal illness.

Exclusion Criteria:

1. Pre-existing conditions that significantly impair mobility prior to injury.
2. Severe renal or liver impairment.
3. Active treatment with investigational drugs or participation in another clinical trial within the last 30 days.
4. Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders.
5. Allergies to any components of the nutritional supplement being tested.

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Medial unloader brace after root repair

    This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.

    Recruiting NYU Langone Health · New York, New York · NCT07909369

  • MAC-STILA: a feasibility test for hip fracture surgery anesthesia

    This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.

    Recruiting NYU Langone Health · Evanston, Illinois and 4 other locations · NCT07897656

  • Osimertinib with Cyclosporine A for EGFR-mutant NSCLC

    This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.

    Recruiting Phase 2 NYU Langone Health · New York, New York · NCT07874490

  • Histotripsy with chemotherapy and immunotherapy for biliary tract cancer

    This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.

    Recruiting NYU Langone Health · New York, New York · NCT07853690

  • A look at why Lewy body conditions cause visual hallucinations

    This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.

    Recruiting NYU Langone Health · New York, New York · NCT07849413

  • Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia

    A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.

    Recruiting NYU Langone Health · New York, New York · NCT07838181

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.